Glaucoma; Drugs
Conditions
Brief summary
Topical Prostaglandin Analog vs Betablocker - Corneal Biomechanical Evaluation using CATS Tonometer Prism
Detailed description
This clinical trial is a prospective, controlled, study and will be performed at one clinical investigative site in Tucson Arizona1. The purpose of this study is to determine if the device, CATS tonometer prism, measures intraocular pressure significantly differently than the current standard of care tonometer prism (Goldmann) before and after institution of topical prostaglandin analogs (PGA) for glaucoma treatment. Fifty percent of patients will be randomly placed on topical beta blockers as a control. The difference PGAs and beta blockers would be a measurement of the amount of corneal biomechanical changes made due to the PGA controlled for the effect of IOP lowering by the beta -blocker group.
Interventions
DEVICECATS Tonometer
latanoprost vs. timolol
DRUGLatanoprost
latanoprost IOP reduction
Sponsors
Intuor Technologies, Inc.
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 101 Years
Healthy volunteers
Yes
Inclusion criteria
* • Male and female patients, at least 18 years of age * Subject has a clear understanding and agrees to all the conditions of the informed consent form
Exclusion criteria
* Subjects shall be selected in accordance with the following
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IOP reduction | 1 month |
Countries
United States
Outcome results
None listed